Formula: | C18H27N5O3 |
Molecular Weight: | 361.45 |
Rotatable Bond Donors: | 4 |
clogP: | 0.44 |
Topological Polar Surface Area: | 78.75 |
Lipinski's RO5: | MW: 361.45 HBA: 8 HBD: 0 RB: 4 LogP: 0.44 |
Rule of Three: | MW: 361.45 HBA: 8 HBD: 0 RB: 4 LogP: 0.44 |
|
ECBD ID | Similarity | Structure | SDF |
---|
ECBD ID | Similarity | Structure | SDF | |
---|---|---|---|---|
EOS32236 | 0.74 | EOS32236 RDKit 3D 25 27 0 0 0 0 0 0 0 0999 V2000 -4.5359 2.0192 -2.1741 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2284 1.5380 -0.8062 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.7704 2.1200 0.3724 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.3609 1.4754 1.5048 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.3484 0.1595 1.1843 S 0 0 0 0 0 0 0 0 0 0 0 0 -3.3830 0.4774 -0.5071 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.6868 -0.3872 -1.4524 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.2476 -0.8201 -2.4600 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.3470 -0.6813 -1.2238 N 0 0 0 0 0 0 0 0 0 0 0 0 -0.5454 0.0026 -0.2168 C 0 0 0 0 0 0 0 0 0 0 0 0 0.9512 -0.2287 -0.3457 C 0 0 1 0 0 0 0 0 0 0 0 0 1.6539 0.3595 0.8815 C 0 0 0 0 0 0 0 0 0 0 0 0 1.1882 1.3150 1.5007 O 0 0 0 0 0 0 0 0 0 0 0 0 2.8968 -0.1738 1.1669 N 0 0 0 0 0 0 0 0 0 0 0 0 3.6931 0.3670 2.2400 C 0 0 0 0 0 0 0 0 0 0 0 0 4.3333 1.6819 1.8538 C 0 0 0 0 0 0 0 0 0 0 0 0 5.7232 1.4424 1.3163 C 0 0 0 0 0 0 0 0 0 0 0 0 4.4135 2.5761 3.0660 C 0 0 0 0 0 0 0 0 0 0 0 0 3.4767 -1.2366 0.3757 C 0 0 0 0 0 0 0 0 0 0 0 0 2.4356 -2.2391 -0.0929 C 0 0 0 0 0 0 0 0 0 0 0 0 1.2912 -1.5985 -0.7024 N 0 0 0 0 0 0 0 0 0 0 0 0 0.5018 -2.3254 -1.5700 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7925 -3.4686 -1.9171 O 0 0 0 0 0 0 0 0 0 0 0 0 -0.6882 -1.5735 -2.1718 C 0 0 2 0 0 0 0 0 0 0 0 0 -0.2089 -0.8012 -3.3842 C 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 2 3 1 0 3 4 2 0 4 5 1 0 5 6 1 0 6 7 1 0 7 8 2 0 7 9 1 0 9 10 1 0 11 10 1 1 11 12 1 0 12 13 2 0 12 14 1 0 14 15 1 0 15 16 1 0 16 17 1 0 16 18 1 0 14 19 1 0 19 20 1 0 20 21 1 0 21 22 1 0 22 23 2 0 22 24 1 0 24 25 1 6 6 2 2 0 24 9 1 0 21 11 1 0 M END $$$$ |
Name | Assay stage | Target | Activity |
---|---|---|---|
GPR35 antagonism | primary assay | G-protein coupled receptor 35 | inactive |